What Is the Aetna and Cigna E/M Downcoding Issue?
As of September 2026, both Aetna and Cigna are using algorithm-based policies to automatically reduce the level of evaluation and management visits billed by physicians, particularly on level 4 and level 5 office visits (99214 and 99215), without reviewing the clinical documentation that supports the code. On September 3, 2026, the AAO-HNS submitted formal opposition letters to both payers challenging these policies and their impact on otolaryngology practices.
Which codes are targeted? Cigna’s R49 policy flags 99204, 99205, 99214, 99215, 99244, and 99245 for automatic downcoding when the payer’s claims algorithm determines the diagnosis does not support the level billed.
Why ENT practices are disproportionately affected: Otolaryngology visits frequently involve complex medical decision-making across multiple organ systems. A single ENT encounter may include nasal endoscopy, allergy evaluation, and cancer screening, all of which legitimately require level 4 or 5 coding.
What happens to downcoded claims? The payer reimburses at the lower level automatically. The practice must then file an appeal with supporting documentation to recover the difference, creating significant administrative cost per claim.
What Aetna and Cigna Changed
Both Aetna and Cigna implemented policies that use claims data and diagnostic algorithms to flag providers whose E/M coding patterns deviate from payer-defined benchmarks. Rather than requesting documentation and reviewing it against CPT guidelines, both payers reduce the billed code automatically and reimburse at the lower level. The provider is then responsible for appealing.
Cigna’s policy, designated R49 and titled ‘Evaluation and Management Coding Accuracy,’ targets visits reported with 99204, 99205, 99214, 99215, 99244, and 99245. When the payer’s system determines that a provider bills these codes at a rate exceeding its threshold, the claims are automatically downcoded. Cigna has cited diagnoses such as ‘earache’ and ‘sore throat’ as examples where lower-level codes should apply, a framing that multiple specialty societies have challenged as overly simplistic.
Aetna’s approach follows a similar model, using algorithm-driven claim reviews rather than chart-level clinical review. The American Academy of Otolaryngology sent individual letters to both payers on September 3, 2026, arguing that automatic downcoding without documentation review violates the intent of the AMA’s CPT coding framework, which requires medical record review to determine the appropriate E/M level.
Which ENT Practices Are Most at Risk?
Any ENT practice that bills Aetna or Cigna for office visits is potentially exposed, but the risk concentrates in practices with high volumes of level 4 and level 5 visits. In otolaryngology, that is most of them. A rhinology-focused practice evaluating chronic sinusitis patients, an otologist managing complex hearing loss, or a head and neck surgeon staging a cancer workup will routinely bill 99214 or 99215 because the medical decision-making genuinely requires it.
Providers often come to us after seeing unexplained drops in average reimbursement per visit. In many cases, the root cause is not a coding error on the practice’s side but a payer-side algorithm that reduced the code before the claim even reached adjudication. Practices with a high percentage of Aetna or Cigna commercial volume feel the impact fastest. Solo practitioners and small groups without dedicated billing staff are the most vulnerable, because they often lack the capacity to appeal at scale. For practices already managing complex coding for procedures like nasal endoscopy (CPT 31231) or laryngoscopy (CPT 31575), an additional layer of E/M appeal work strains resources further.
How Downcoding Changes Your Reimbursement
The financial impact depends on the volume of affected visits. Here is what shifts when a level 4 visit is automatically reduced to level 3.
| Factor | Before Downcoding | After Downcoding |
| Code billed | 99214 | 99213 |
| Medicare national rate (non-facility) | Approximately $130 to $145 | Approximately $95 to $105 |
| Commercial rate (varies) | $160 to $220+ | $110 to $145 |
| Revenue loss per visit | None | $30 to $75+ per visit |
| Appeal required | No | Yes, with full documentation |
| Staff time per appeal | None | 30 to 60 minutes per claim |
The per-visit numbers may look small, but across a practice seeing 25 to 40 Aetna or Cigna patients per week, the annual impact can reach $40,000 to $100,000 or more in lost revenue before accounting for the cost of appeals. The most common issue we see providers run into is not realizing the downcoding is happening until several months of reduced payments have already posted.
Dealing with payer downcoding or unexplained drops in E/M reimbursement? Get matched with ENT billing companies that specialize in payer appeals and coding defense, at no cost to your practice. Rates start as low as 2.95%.
How to Protect Your Practice from E/M Downcoding
If your practice bills Aetna or Cigna for level 4 or 5 E/M visits, take these steps now:
1. Audit your explanation of benefits (EOBs) from the last 90 days for any Aetna or Cigna E/M visit that was paid at a lower level than billed.
2. Pull your claims data to identify how many 99214 and 99215 visits were reduced to 99213 or 99212 by payer, and calculate the total revenue difference.
3. Review your documentation templates to confirm that every office visit note explicitly supports the billed E/M level through documented medical decision-making or total time.
4. Establish a systematic appeal process for every downcoded claim, including a standard cover letter citing CPT guidelines and AMA documentation requirements.
5. Track appeal outcomes by payer to build a record of overturn rates, which strengthens future appeals and may support escalation to your state insurance commissioner.
6. Contact your state medical society and the AAO-HNS to add your practice’s experience to the formal record opposing these policies.
In our experience matching providers with billing partners, practices that track downcoding patterns by payer and appeal systematically recover 60% to 80% of the lost revenue. The ones that do not track it absorb the loss indefinitely. Specialized billing companies with payer appeal experience can handle this workflow without adding headcount to your office. For practices also managing procedural coding complexity on codes like tympanostomy tube insertion (CPT 69436) or comprehensive audiometry (CPT 92557), outsourcing the E/M appeal layer keeps the billing team focused on the procedural side.
Common Mistakes When Responding to Payer Downcoding
Accepting the lower payment without checking: Many practices do not review EOBs line by line. If the claim pays, they move on. Downcoded claims still pay, just at a lower rate, so the loss is invisible without a deliberate audit.
Assuming the payer is right: CPT coding is determined by medical record documentation, not by diagnosis code alone. A visit for ‘sore throat’ (J02.9) can legitimately support a 99215 if the medical decision-making involves cancer screening, imaging review, or complex differential diagnosis. The payer’s algorithm does not account for this.
Appealing without documentation: An appeal that says ‘we disagree’ without attaching the visit note, a reference to CPT guidelines, and a clear explanation of why the medical decision-making supports the higher level will be denied.
Changing coding behavior to avoid the flag: Some practices begin billing 99213 for visits that genuinely warrant 99214 to avoid triggering the algorithm. This is undercoding, and it is also a compliance risk. Bill the level the documentation supports.
Not involving the specialty society: The AAO-HNS and other organizations are actively building a case against these policies. Individual practice data strengthens the advocacy effort.
Should You Handle Appeals In-House or Outsource?
The answer depends on your volume and your team’s capacity. If your practice sees fewer than 10 downcoded claims per month, an experienced in-house billing manager can handle the appeals as part of their regular workflow. The process is straightforward: pull the note, attach it to a template appeal letter, submit it through the payer portal, and track the outcome.
For practices seeing 20 or more downcoded claims per month, the appeal volume starts to pull your billing team away from charge capture, follow-up, and denial management on the procedural side. At that point, the cost of the appeals in staff hours often exceeds the cost of outsourcing them to a billing company with dedicated payer appeal infrastructure.
One question we hear constantly from practice managers is whether outsourcing just the appeal work is an option, rather than the full billing cycle. It is. Many of the billing companies in our network offer modular services, including standalone payer appeal and denial management. That lets the practice keep its current billing workflow intact while handing off the most labor-intensive piece.
Frequently Asked Questions
Is Aetna and Cigna downcoding already in effect?
Yes. Cigna’s R49 policy became active in late 2025, and Aetna’s algorithm-based downcoding has been in effect for commercial and Medicare Advantage lines. Both payers are currently applying these policies to claims. The AAO-HNS submitted formal opposition letters on September 3, 2026.
Which E/M codes are being downcoded?
Cigna’s policy targets 99204, 99205, 99214, 99215, 99244, and 99245. Aetna’s approach is similar, focusing on level 4 and level 5 office visits where the payer’s algorithm flags the provider’s coding frequency as above its benchmark.
Can I appeal a downcoded ENT visit?
Yes. Both payers allow appeals. Submit the full office visit note, a cover letter explaining why the medical decision-making or total time supports the billed level, and a reference to AMA CPT documentation guidelines. Track every appeal and its outcome.
Does this affect Medicare or only commercial plans?
The Cigna and Aetna policies primarily affect commercial and Medicare Advantage lines. Traditional Medicare does not use automatic downcoding algorithms, though it has its own audit and review processes through Medicare Administrative Contractors.
How much revenue can a practice lose to downcoding?
The loss depends on the payer mix and visit volume. A practice billing 30 to 50 level 4 or 5 visits per week to Aetna or Cigna could lose $40,000 to $100,000 or more annually if the downcoded claims are not appealed.
Should I start billing lower codes to avoid being flagged?
No. Billing a lower code than the documentation supports is undercoding, which is a compliance risk. Bill the level your medical record documentation supports. If the payer reduces it, appeal with the documentation.
Has AAO-HNS taken action on this issue?
Yes. The AAO-HNS submitted individual comment letters to Aetna and Cigna on September 3, 2026, challenging both policies. The Academy argues that automatic downcoding without documentation review violates AMA CPT coding framework principles.
Next Steps
Review your Aetna and Cigna EOBs from the last 90 days and flag any E/M visit paid below the billed level. If you find a pattern, calculate the total revenue impact and begin systematic appeals.
For a full reference on the ENT procedure codes most commonly billed alongside these E/M visits, see our guides on nasal endoscopy (CPT 31231) and flexible laryngoscopy (CPT 31575).
If your billing team does not have capacity to manage a high volume of payer appeals, get matched with an ENT billing company that handles appeal workflows at scale.
Stop losing revenue to automatic downcoding. Get matched with ENT medical billing companies that know how to defend E/M coding and win payer appeals, backed by 15+ years of experience and rates starting as low as 2.95%.
